Baum Andrew bought PFE
March 3, 2026 · Form 4 insider transaction
Baum Andrew bought 303,151 shares of Pfizer Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
303,151
Price
$0.00
Total value
N/A
InsiderBaum Andrew
Role—
CompanyPfizer Inc. (PFE)
SecurityStock Appreciation Rights
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after303,151
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.